Payment overview · 2025
General Payments
$56.47
2 reported records · 1 companies
Healthcare provider profile · identity verified
Christopher Scott Connelly, MD
Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Clinical Neurophysiology · CONCORD, NC · NPI 1457321978
Verified facts
What the public records show
CMS Open Payments records show Christopher Scott Connelly, MD received $56.47 in general payments during 2025 across 2 reported records.
Amgen Inc. accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Amgen Inc. | Unresolved — no canonical attribution shown | $56.47 | 100.0% | 2 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $56.47 | 2 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| UPLIZNA Normalized: uplizna |
Biological | Amgen Inc. | $56.47 | 2 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Gabapentin | Gabapentin | 546 | 124 |
| Duloxetine Hcl | Duloxetine Hcl | 464 | 92 |
| Topiramate | Topiramate | 415 | 89 |
| Donepezil Hcl | Donepezil Hcl | 352 | 85 |
| Buspirone Hcl | Buspirone Hcl | 309 | 68 |
| Nortriptyline Hcl | Nortriptyline Hcl | 285 | 80 |
| Pregabalin | Pregabalin | 271 | 69 |
| Fluoxetine Hcl | Fluoxetine Hcl | 232 | 56 |
| Baclofen | Baclofen | 230 | 54 |
| Clonazepam | Clonazepam | 218 | 35 |
| Primidone | Primidone | 212 | 50 |
| Levetiracetam | Levetiracetam | 200 | 39 |
| Tramadol Hcl | Tramadol Hcl | 182 | 42 |
| Alprazolam | Alprazolam | 180 | 26 |
| Mirtazapine | Mirtazapine | 157 | 42 |
| Tizanidine Hcl | Tizanidine Hcl | 153 | 39 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 147 | 40 |
| Zolpidem Tartrate | Zolpidem Tartrate | 141 | 29 |
| Aimovig Autoinjector | Erenumab-Aooe | 135 | 28 |
| Temazepam | Temazepam | 134 | 27 |
| Celecoxib | Celecoxib | 132 | 35 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 126 | 19 |
| Clopidogrel | Clopidogrel Bisulfate | 125 | 29 |
| Lamotrigine | Lamotrigine | 125 | 18 |
| Zonisamide | Zonisamide | 124 | 25 |
| Propranolol Hcl Er | Propranolol Hcl | 118 | 25 |
| Potassium Chloride | Potassium Chloride | 110 | 21 |
| Lisinopril | Lisinopril | 108 | 35 |
| Quetiapine Fumarate | Quetiapine Fumarate | 104 | 24 |
| Butalbital-Acetaminophen-Caffe | Butalb/Acetaminophen/Caffeine | 103 | 36 |
| Amantadine | Amantadine Hcl | 100 | 27 |
| Prednisone | Prednisone | 98 | 54 |
| Divalproex Sodium Er | Divalproex Sodium | 97 | 17 |
| Galantamine Er | Galantamine Hbr | 97 | 25 |
| Trazodone Hcl | Trazodone Hcl | 96 | 23 |
| Atorvastatin Calcium | Atorvastatin Calcium | 95 | 27 |
| Diazepam | Diazepam | 93 | 34 |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 93 | 16 |
| Bupropion Xl | Bupropion Hcl | 91 | 19 |
| Propranolol Hcl | Propranolol Hcl | 90 | 22 |
| Rizatriptan | Rizatriptan Benzoate | 86 | 21 |
| Sumatriptan Succinate | Sumatriptan Succinate | 83 | 24 |
| Sertraline Hcl | Sertraline Hcl | 82 | 23 |
| Memantine Hcl | Memantine Hcl | 81 | 24 |
| Meloxicam | Meloxicam | 79 | 27 |
| Amlodipine Besylate | Amlodipine Besylate | 75 | 24 |
| Divalproex Sodium | Divalproex Sodium | 74 | 14 |
| Omeprazole | Omeprazole | 73 | 19 |
| Carbamazepine Er | Carbamazepine | 63 | 14 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 62 | 16 |
| Fludrocortisone Acetate | Fludrocortisone Acetate | 60 | 12 |
| Ondansetron Hcl | Ondansetron Hcl | 59 | 16 |
| Amitriptyline Hcl | Amitriptyline Hcl | 55 | suppressed |
| Carbamazepine | Carbamazepine | 55 | suppressed |
| Modafinil | Modafinil | 55 | suppressed |
| Hydrochlorothiazide | Hydrochlorothiazide | 53 | suppressed |
| Qulipta | Atogepant | 53 | 13 |
| Oxycodone Hcl | Oxycodone Hcl | 52 | suppressed |
| Savella | Milnacipran Hcl | 51 | suppressed |
| Ubrelvy | Ubrogepant | 43 | 15 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 41 | suppressed |
| Carbidopa-Levodopa Er | Carbidopa/Levodopa | 40 | suppressed |
| Emgality Syringe | Galcanezumab-Gnlm | 40 | suppressed |
| Levothyroxine Sodium | Levothyroxine Sodium | 40 | 11 |
| Ropinirole Hcl | Ropinirole Hcl | 40 | 12 |
| Desmopressin Acetate | Desmopressin Acetate | 39 | 11 |
| Pantoprazole Sodium | Pantoprazole Sodium | 39 | suppressed |
| Promethazine Hcl | Promethazine Hcl | 37 | 11 |
| Methylphenidate Hcl | Methylphenidate Hcl | 36 | suppressed |
| Lacosamide | Lacosamide | 34 | suppressed |
| Olanzapine | Olanzapine | 34 | suppressed |
| Lorazepam | Lorazepam | 32 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 32 | suppressed |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 32 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 31 | suppressed |
| Famotidine | Famotidine | 31 | suppressed |
| Ibuprofen | Ibuprofen | 29 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 28 | suppressed |
| Ondansetron Odt | Ondansetron | 28 | suppressed |
| Dalfampridine Er | Dalfampridine | 27 | suppressed |
| Pravastatin Sodium | Pravastatin Sodium | 26 | suppressed |
| Nurtec Odt | Rimegepant Sulfate | 25 | suppressed |
| Aripiprazole | Aripiprazole | 24 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 24 | 13 |
| Naproxen | Naproxen | 24 | suppressed |
| Naratriptan Hcl | Naratriptan Hcl | 24 | 12 |
| Clorazepate Dipotassium | Clorazepate Dipotassium | 23 | suppressed |
| Escitalopram Oxalate | Escitalopram Oxalate | 23 | suppressed |
| Oxcarbazepine | Oxcarbazepine | 23 | suppressed |
| Fluticasone Propionate | Fluticasone Propionate | 21 | suppressed |
| Losartan Potassium | Losartan Potassium | 21 | suppressed |
| Teriflunomide | Teriflunomide | 21 | suppressed |
| Vumerity | Diroximel Fumarate | 21 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 20 | suppressed |
| Ipratropium Bromide | Ipratropium Bromide | 20 | suppressed |
| Phenobarbital | Phenobarbital | 20 | suppressed |
| Carbidopa | Carbidopa | 19 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 19 | suppressed |
| Eliquis | Apixaban | 19 | suppressed |
| Emgality Pen | Galcanezumab-Gnlm | 19 | suppressed |
| Ingrezza | Valbenazine Tosylate | 19 | suppressed |
| Ropinirole Er | Ropinirole Hcl | 19 | suppressed |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 18 | suppressed |
| Dimethyl Fumarate | Dimethyl Fumarate | 18 | suppressed |
| Eszopiclone | Eszopiclone | 18 | suppressed |
| Galantamine Hbr | Galantamine Hbr | 18 | suppressed |
| Acetazolamide | Acetazolamide | 17 | suppressed |
| Ajovy Autoinjector | Fremanezumab-Vfrm | 17 | suppressed |
| Belsomra | Suvorexant | 17 | suppressed |
| Diclofenac Potassium | Diclofenac Potassium | 17 | suppressed |
| Imipramine Hcl | Imipramine Hcl | 17 | suppressed |
| Desvenlafaxine Succinate Er | Desvenlafaxine Succinate | 16 | suppressed |
| Myrbetriq | Mirabegron | 16 | suppressed |
| Pyridostigmine Bromide | Pyridostigmine Bromide | 16 | suppressed |
| Carbatrol | Carbamazepine | 15 | suppressed |
| Chlorpromazine Hcl | Chlorpromazine Hcl | 15 | suppressed |
| Doxepin Hcl | Doxepin Hcl | 15 | suppressed |
| Prochlorperazine Maleate | Prochlorperazine Maleate | 15 | suppressed |
| Austedo | Deutetrabenazine | 14 | suppressed |
| Risperidone | Risperidone | 14 | suppressed |
| Valsartan | Valsartan | 14 | suppressed |
| Asenapine Maleate | Asenapine Maleate | 13 | suppressed |
| Entacapone | Entacapone | 13 | suppressed |
| Fingolimod | Fingolimod Hcl | 13 | suppressed |
| Linzess | Linaclotide | 13 | suppressed |
| Nuplazid | Pimavanserin Tartrate | 13 | suppressed |
| Oxycontin | Oxycodone Hcl | 13 | suppressed |
| Bupropion Hcl | Bupropion Hcl | 12 | suppressed |
| Cymbalta | Duloxetine Hcl | 12 | suppressed |
| Fluphenazine Hcl | Fluphenazine Hcl | 12 | suppressed |
| Furosemide | Furosemide | 12 | suppressed |
| Methadone Hcl | Methadone Hcl | 12 | suppressed |
| Montelukast Sodium | Montelukast Sodium | 12 | suppressed |
| Rasagiline Mesylate | Rasagiline Mesylate | 12 | suppressed |
| Scopolamine | Scopolamine | 12 | suppressed |
| Simvastatin | Simvastatin | 12 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 11 | suppressed |
| Clobazam | Clobazam | 11 | suppressed |
| Eletriptan Hbr | Eletriptan Hydrobromide | 11 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 11 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $56.47 · 2 records | Amgen Inc. | UPLIZNA | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error